As of 2024-12-14, the Relative Valuation of Reata Pharmaceuticals Inc (RETA) is (63.78) USD. This relative valuation is based on P/E multiples. With the latest stock price at 172.36 USD, the upside of Reata Pharmaceuticals Inc based on Relative Valuation is -137.0%.
The range of the Relative Valuation is (45.24) - (70.75) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 17.3x - 27.1x | 24.0x |
| Forward P/E multiples | 17.3x - 27.5x | 24.9x |
| Fair Price | (45.24) - (70.75) | (63.78) |
| Upside | -126.2% - -141.0% | -137.0% |
| Date | P/E |